Clinical Trial: First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163403) titled 'First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers' on July 30.

Brief Summary: Tha aim of this clinical trial is to evaluate safety and tolerability of autologous peripheral blood differentiated and matured adult dendritic cells. Immunogenicity of the prduct(DC-DELAY) will be evaluated also.

Study Start Date: Sept. 04

Study Type: INTERVENTIONAL

Condition: Lynch Syndrome

Intervention: BIOLOGICAL: Autologous Tolerogenic Dendritic cells

Autologous peripheral blood differentiated and matured adult de...